Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID-19 Adenovirus Vector Vaccines on European Healthcare Professionals.
van Vliet E, Lipovec NČ, van der Goot M, Abtahi S, Ribeiro-Vaz I, Poplavska E, Dermiki-Gkana F, Oikonomou C, Deligianni E, Kontogiorgis C, Silva AM, Ferreira PBS, Kos M, Almarsdóttir AB, Jacobsen R, Buhl C, de Bruijn A, Hegger I, Alves TL. van Vliet E, et al. Among authors: alves tl. Pharmacoepidemiol Drug Saf. 2024 Dec;33(12):e70057. doi: 10.1002/pds.70057. Pharmacoepidemiol Drug Saf. 2024. PMID: 39586738 Free PMC article.
Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions - A cross-sectional study in six EU member states.
Buhl C, Jacobsen R, Almarsdóttir AB, Abtahi S, Andersen A, Deligianni E, Dermiki-Gkana F, Kontogiorgis C, Oikonomou C, Kursite M, Poplavska E, Hegger I, van der Goot M, Sousa Ferreira PB, Ribeiro-Vaz I, Silva AM, Kos M, Lipovec NČ, van Vliet E, Alves TL. Buhl C, et al. Among authors: alves tl. Vaccine. 2024 Jan 25;42(3):556-563. doi: 10.1016/j.vaccine.2023.12.065. Epub 2024 Jan 4. Vaccine. 2024. PMID: 38182460 Free article.
Scenarios for 3D printing of personalized medicines - A case study.
Beer N, Hegger I, Kaae S, De Bruin ML, Genina N, Alves TL, Hoebert J, Kälvemark Sporrong S. Beer N, et al. Among authors: alves tl. Explor Res Clin Soc Pharm. 2021 Sep 25;4:100073. doi: 10.1016/j.rcsop.2021.100073. eCollection 2021 Dec. Explor Res Clin Soc Pharm. 2021. PMID: 35479838 Free PMC article.
Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study.
Møllebæk M, Gardarsdottir H, Bikou AG, Kodrič A, Silva AM, Andersen A, Kontogiorgis C, Poplavska E, Ahmadizar F, Dermiki-Gkana F, Rutkovska I, Vaz IR, Kos M, Barão P, Grupstra R, Alves TL, Almarsdóttir AB. Møllebæk M, et al. Among authors: alves tl. Drug Saf. 2024 Nov 21. doi: 10.1007/s40264-024-01487-5. Online ahead of print. Drug Saf. 2024. PMID: 39570566
The evolution of knowledge on genes associated with human diseases.
Lüscher-Dias T, Siqueira Dalmolin RJ, de Paiva Amaral P, Alves TL, Schuch V, Franco GR, Nakaya HI. Lüscher-Dias T, et al. Among authors: alves tl. iScience. 2021 Dec 11;25(1):103610. doi: 10.1016/j.isci.2021.103610. eCollection 2022 Jan 21. iScience. 2021. PMID: 35005554 Free PMC article.
38 results